“Pharmaceutical companies are not investing in this research because DCA method cannot be patented, without a patent they can’t make money, like they are doing now with their AIDS Patent. Since the pharmaceutical companies won’t develop this, the article says other independent laboratories should start producing this drug and do more research to confirm all the above findings and produce drugs. All the groundwork can be done in collaboration with the Universities, who will be glad to assist in such research and can develop an effective drug for curing cancer.”
For many years, alternative, both in the sense of ‘natural’ and of ‘different to normal’, cancer treatments have been suggested. It is true to say that in all cases there is an obvious reluctance of the established cancer research and treatment “industry” to ignore or refute them.
The suggestion here that the potential cure (DCA) deserves serious consideration is well supported.
It would be understandable that the mega-million dollar cancer industry would have a serious vested-interest motivation for not supporting a genuine non-profit-making solution to cancer suffering and deaths. WHO in the world would be powerful enough to intercede and have a humanitarian motivation for saving lives?
Note that there is a great deal of world-wide enthusiasm for reducing the global population, some of it involving the so-called health organizations and, in particular, involving vaccinations.
Thus, our expectations for serious research and follow up of this suggested method, should not be too high.